We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Brazil Requires One-Year Notice of Drug Withdrawals to Avert Shortages
Brazil Requires One-Year Notice of Drug Withdrawals to Avert Shortages
Drugmakers must now give Brazil’s Anvisa a full year’s warning before withdrawing a product from the market if the withdrawal could result in a drug shortage.
To View This Article:
Login
Subscribe To International Pharmaceutical Regulatory Monitor